Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient. [electronic resource]
Producer: 20101028Description: 2792-5 p. digitalISSN:- 1460-2385
- Adult
- Antiviral Agents -- therapeutic use
- Chronic Disease
- Dose-Response Relationship, Drug
- Hepatitis E -- drug therapy
- Hepatitis E virus
- Humans
- Immunosuppressive Agents -- therapeutic use
- Interferon alpha-2
- Interferon-alpha -- therapeutic use
- Kidney Failure, Chronic -- therapy
- Kidney Transplantation -- immunology
- Male
- Nephritis, Hereditary -- surgery
- Opportunistic Infections -- drug therapy
- Polyethylene Glycols -- therapeutic use
- Recombinant Proteins
- Renal Dialysis
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.